Clinical trials are research studies that are key to learning more about kidney cancer and can also give patients access to innovative new treatments. The IKCC global patient survey shows that 89% of kidney cancer patients would consider being part of a clinical trial if they were asked. But fewer than half are ever asked. Of those patients who do participate in clinical trials, the vast majority report having a positive experience.
If you are interested in clinical trials, find out more here and talk to your doctor about whether there are any trials suitable for you.